Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
Hafnia
HAFN
$5.12B
| $1.94M | ﹤0.01% |
363,459
+95,274
| +36% | +$568K |
2024 Q2
6 quarters
|
|
2927
Hallador Energy
HNRG
$636M
| $1.93M | ﹤0.01% |
101,495
-17,114
| -14% | -$347K |
2022 Q4
12 quarters
|
|
2928
Protolabs
PRLB
$2.35B
| $1.93M | ﹤0.01% |
38,149
+3,899
| +11% | +$199K |
2016 Q1
39 quarters
|
|
|
KE
2929
Kimball Electronics
KE
$691M
| $1.93M | ﹤0.01% |
69,334
+498
| +0.7% | +$14.4K |
2016 Q2
38 quarters
|
|
2930
Phreesia
PHR
$625M
| $1.93M | ﹤0.01% |
113,941
+21,605
| +23% | +$446K |
2022 Q1
15 quarters
|
|
2931
SELLAS Life Sciences
SLS
$2.37B
| $1.93M | ﹤0.01% |
511,034
+328,354
| +180% | +$638K |
2025 Q2
2 quarters
|
|
|
PRA
2932
DELISTED
ProAssurance
PRA
| $1.92M | ﹤0.01% |
79,644
+7,475
| +10% | +$180K |
2013 Q2
50 quarters
|
|
2933
Grindr
GRND
$2.33B
| $1.92M | ﹤0.01% |
142,054
-5,097
| -3% | -$69.3K |
2023 Q1
11 quarters
|
|
2934
Avalo Therapeutics
AVTX
$804M
| $1.92M | ﹤0.01% |
105,814
+96,468
| +1,032% | +$1.63M |
2025 Q3
1 quarter
|
|
2935
Gentherm
THRM
$962M
| $1.92M | ﹤0.01% |
52,758
+2,240
| +4% | +$80.7K |
2013 Q2
50 quarters
|
|
2936
CALL
Coca-Cola
KO
$369B
| $1.92M | ﹤0.01% |
27,400
+3,200
| +13% | +$223K |
2023 Q4
8 quarters
|
|
2937
Emergent Biosolutions
EBS
$325M
| $1.91M | ﹤0.01% |
154,892
-25,258
| -14% | -$271K |
2013 Q2
50 quarters
|
|
2938
Marten Transport
MRTN
$1.09B
| $1.91M | ﹤0.01% |
167,887
+26,098
| +18% | +$277K |
2016 Q1
39 quarters
|
|
2939
U-Haul Holding Co
UHAL
$12B
| $1.9M | ﹤0.01% |
37,772
+24,915
| +194% | +$1.33M |
2015 Q2
42 quarters
|
|
2940
Cogent Communications
CCOI
$433M
| $1.9M | ﹤0.01% |
88,314
+22,741
| +35% | +$671K |
2013 Q2
50 quarters
|
|
2941
Bumble
BMBL
$335M
| $1.9M | ﹤0.01% |
532,896
-848,038
| -61% | -$3.76M |
2022 Q1
15 quarters
|
|
2942
Pagaya Technologies
PGY
$1.5B
| $1.9M | ﹤0.01% |
+91,008
| New | +$2.32M |
2025 Q4
0 quarters
|
|
2943
CALL
Rapid7
RPD
$822M
| $1.9M | ﹤0.01% |
125,000
-30,000
| -19% | -$494K |
2025 Q1
3 quarters
|
|
2944
Klaviyo
KVYO
$4.47B
| $1.89M | ﹤0.01% |
58,292
+12,459
| +27% | +$349K |
2024 Q1
7 quarters
|
|
2945
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$161B
| $1.89M | ﹤0.01% |
97,896
+86,356
| +748% | +$1.5M |
2023 Q3
9 quarters
|
|
|
ORC
2946
Orchid Island Capital
ORC
$1.01B
| $1.89M | ﹤0.01% |
262,543
+58,917
| +29% | +$429K |
2016 Q4
36 quarters
|
|
2947
AMC Entertainment Holdings
AMC
$2.47B
| $1.89M | ﹤0.01% |
1,209,841
-1,942,202
| -62% | -$4.63M |
2023 Q4
8 quarters
|
|
2948
US Physical Therapy
USPH
$1.25B
| $1.89M | ﹤0.01% |
24,161
+2,823
| +13% | +$229K |
2016 Q2
38 quarters
|
|
2949
Olin
OLN
$1.81B
| $1.88M | ﹤0.01% |
90,243
-69,457
| -43% | -$1.5M |
2013 Q2
50 quarters
|
|
2950
TETRA Technologies
TTI
$888M
| $1.88M | ﹤0.01% |
200,371
+15,307
| +8% | +$118K |
2021 Q1
19 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.